147 related articles for article (PubMed ID: 35675672)
1. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers:
Polat HK; Kurt N; Aytekin E; Akdağ Çaylı Y; Bozdağ Pehlivan S; Çalış S
J Ocul Pharmacol Ther; 2022; 38(6):412-423. PubMed ID: 35675672
[No Abstract] [Full Text] [Related]
2. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation.
Polat HK; Bozdağ Pehlivan S; Özkul C; Çalamak S; Öztürk N; Aytekin E; Fırat A; Ulubayram K; Kocabeyoğlu S; İrkeç M; Çalış S
Int J Pharm; 2020 Jul; 585():119552. PubMed ID: 32569814
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
[TBL] [Abstract][Full Text] [Related]
4. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
5. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
Youssef AAA; Dudhipala N; Majumdar S
Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
8. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
[TBL] [Abstract][Full Text] [Related]
9. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy.
Pyo YC; Tran P; Kim DH; Park JS
Colloids Surf B Biointerfaces; 2020 Dec; 196():111331. PubMed ID: 32906001
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
Shrivastava N; Khan S; Baboota S; Ali J
Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
[TBL] [Abstract][Full Text] [Related]
12. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
13. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
[TBL] [Abstract][Full Text] [Related]
14. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
Liu D; Li J; Cheng B; Wu Q; Pan H
Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole.
Patil A; Tuencar V; Gadad A; Dandagi P; Masareddy R
Ther Deliv; 2021 Aug; 12(8):565-574. PubMed ID: 34187177
[No Abstract] [Full Text] [Related]
16. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment.
Imam SS; Bukhari SNA; Ali A
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):959-967. PubMed ID: 28708424
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
[TBL] [Abstract][Full Text] [Related]
19. Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis.
Üstündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ertan G; Özer Ö
Expert Opin Drug Deliv; 2015; 12(11):1791-807. PubMed ID: 26159181
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]